Tech Company Financing Transactions
Dermira Funding Round
Dermira, based in Redwood City, secured $42 million in funding from Bay City Capital, Canaan Partners and New Enterprise Associates.
Transaction Overview
Company Name
Announced On
10/20/2011
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series A
Investors
Proceeds Purpose
Funds will be used to advance the product pipeline, specifically, lemuteporfin, a potent and selective topical photodynamic therapy (PDT) for acne, licensed from QLT Inc., as well as a robust pipeline of novel, topical small molecule therapeutics for sebaceous gland hyperactivity and inflammatory skin diseases.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
275 Middlefield Rd. 150
Redwood City, CA 94025
USA
Redwood City, CA 94025
USA
Phone
Website
Email Address
Overview
Dermira is a biotech company focused on developing and commercializing innovative new therapies in dermatology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Thomas Wiggans
Chief Medical Officer
Eugene Bauer
Chief Operating Officer
Andrew Guggenhime
VP - Bus. Development
Chris Griffith
VP - Bus. Development
Luis Peña
Browse more venture capital transactions:
Prev: 10/20/2011: MicroPhage venture capital transaction
Next: 10/20/2011: UltraSolar Technology venture capital transaction
Share this article
About Our VC Transactions Data
We document tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs